Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Sulfurous Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.86 |
| ▸ | CA2 | P00918 | 1/20 | 0.86 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL11420457 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL10568829 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL3649362 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL9147495 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL2720680 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL1010459 | 1.00 | — | — | |
| Sulfurous Acid SCHEMBL11014697 | 0.94 | CA1 (0.75) | CA1CA2 | |
| Sulfurous Acid SCHEMBL4445469 | 0.94 | — | — | |
| Sulfurous Acid SCHEMBL8365361 | 0.94 | — | — | |
| Sulfurous Acid SCHEMBL21326219 | 0.94 | CA1 (0.75) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2490670-A2 | COMPOSITION FOR INHALATION | Innovata Limited (GB) | 2012-08-29 | — | — | EP | claimed |
| EP-2200682-B1 | HYPODERMIC NEEDLE WITH WATER-SOLUBLE OBSTRUCTION FOR THE ADMINISTRATION OF DRUGS AND VACCINES | AZUREBIO S L (ES) | 2012-02-08 | — | — | EP | claimed |
| WO-2011048379-A2 | COMPOSITION | INNOVATA LIMITED (GB) | 2011-04-28 | — | — | WO | claimed |
| US-20100286598-A1 | HYPODERMIC NEEDLE WITH WATER-SOLUBLE OBSTRUCTION FOR THE ADMINISTRATION OF DRUGS AND VACCINES | AZUREBIO S.L.U. (ES) | 2010-11-11 | — | — | US | claimed |
| EP-2200682-A1 | HYPODERMIC NEEDLE WITH WATER-SOLUBLE OBSTRUCTION FOR THE ADMINISTRATION OF DRUGS AND VACCINES | Azurebio S.L.U (ES) | 2010-06-30 | — | — | EP | claimed |
| WO-2009047276-A1 | HYPODERMIC NEEDLE WITH WATER-SOLUBLE OBSTRUCTION FOR THE ADMINISTRATION OF DRUGS AND VACCINES | AZUREBIO S.L.U (ES) | 2009-04-16 | — | — | WO | claimed |
| US-20020012687-A1 | Solid dose delivery vehicle and methods of making same | QDOSE LIMITED (GB) | 2002-01-31 | — | — | US | claimed |
| EP-0415567-A2 | Composition and method for stabilising organic compounds | QUADRANT BIORESOURCES LIMITED (GB) | 1991-03-06 | — | — | EP | claimed |
| EP-0353281-A1 | METHOD OF DRYING MACROMOLECULES | QUADRANT BIORESOURCES LIMITED (GB) | 1990-02-07 | — | — | EP | claimed |
| WO-1989006976-A1 | METHOD OF DRYING MACROMOLECULES | QUADRANT BIORESOURCES LIMITED (GB) | 1989-08-10 | — | — | WO | claimed |
| EP-4673584-A1 | SOLID MOLDED SULFITE-BASED OXYGEN SCAVENGER COMPOSITION AND METHOD OF MANUFACTURE | NCH Corporation (US) | 2026-01-07 | — | — | EP | disclosed |
| CN-119191527-A | Fenton reagent preparation method based on waste lithium iron phosphate electrode material and application thereof | 大连大学 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024182716-A1 | SOLID MOLDED SULFITE-BASED OXYGEN SCAVENGER COMPOSITION AND METHOD OF MANUFACTURE | NCH CORPORATION (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240295031-A1 | Solid Molded Sulfite-Based Oxygen Scavenger Composition and Method of Manufacutre | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2024-09-05 | — | — | US | disclosed |
| US-9457038-B2 | Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies | GALDERMA S.A. (CH) | 2016-10-04 | — | — | US | disclosed |
| WO-1999045006-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER INC. (US) | 1999-09-10 | — | — | WO | disclosed |
| EP-0415567-A2 | Composition and method for stabilising organic compounds | QUADRANT BIORESOURCES LIMITED (GB) | 1991-03-06 | — | — | EP | disclosed |
| EP-0353281-A1 | METHOD OF DRYING MACROMOLECULES | QUADRANT BIORESOURCES LIMITED (GB) | 1990-02-07 | — | — | EP | disclosed |
| WO-1989006976-A1 | METHOD OF DRYING MACROMOLECULES | QUADRANT BIORESOURCES LIMITED (GB) | 1989-08-10 | — | — | WO | disclosed |
| US-4104192-A | COMPRISING A DITHIONITE AND A COMPOUND HAVING WATER OF HYDRATION OR WATER OF CRYSTALLIZATION | MITSUBISHI GAS CHEMICAL COMPANY INC. (JP) | 1978-08-01 | — | — | US | disclosed |